Порівняння методів
Переглядайте обрані методи поруч; рядки з відмінностями підсвічено.
| CushQoL: Опитувальник якості життя при синдромі Кушинга× | ThyPRO: Шкала оцінки стану пацієнтів, пов'язаного з щитоподібною залозою× | |
|---|---|---|
| Галузь | Ендокринологія | Ендокринологія |
| Родина | Process / pipeline | Process / pipeline |
| Рік появи≠ | 2008 | 2009 |
| Автор методу≠ | Sergio Webb, María D. Bernal, Juan M. Rivera-Caravaca | Torquil Watt, Jens Bjørner, Marianne Groenvold |
| Тип | Patient self-report questionnaire | Patient self-report questionnaire |
| Основоположне джерело≠ | Webb, S. M., Bernal, M. D., Rivera-Caravaca, J. M., & Córdoba-Soriano, J. G. (2008). Development and validation of CushQoL, a disease-specific quality of life questionnaire in Cushing's syndrome. J Clin Endocrinol Metab, 93(5), 1751-1759. link ↗ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ |
| Інші назви | Cushing QoL, CS-QoL | ThyPRO-85, ThyPRO-39 |
| Пов'язані | 3 | 3 |
| Підсумок≠ | CushQoL is a disease-specific 12-item quality of life questionnaire developed to assess the multidimensional impacts of Cushing's syndrome—a severe endocrine disorder characterized by excess cortisol production. Developed by Webb and colleagues in 2008, it captures physical symptoms (fatigue, weight gain, weakness, hirsutism), psychological manifestations (depression, anxiety, cognitive impairment), and social/occupational dysfunction unique to Cushing's syndrome. It is the standard outcome measure for assessing quality of life improvement following curative therapy. | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. |
| ScholarGateНабір даних ↗ |
|
|